Earnings Call Insights: Alliance Laundry Holdings Inc. (ALH) Q1 2026 Management view CEO Michael Schoeb said Q1 was “broad-based, driven by both volume and price,” and highlighted that “revenue grew 10% year-over-year with adjusted EBITDA growth of 9% and adjusted net income almost doubling.” He tied the guidance raise to “the strength and breadth of this performance, combined with our growing vis...
Earnings Call Insights: Alliance Laundry Holdings Inc. (ALH) Q1 2026 Management view CEO Michael Schoeb said Q1 was “broad-based, driven by both volume and price,” and highlighted that “revenue grew 10% year-over-year with adjusted EBITDA growth of 9% and adjusted net income almost doubling.” He tied the guidance raise to “the strength and breadth of this performance, combined with our growing visibility into the balance of the year.” Schoeb emphasized tariffs positioning, saying “our local-for-local manufacturing strategy continues to be a real competitive advantage,” and added that Alliance is “in a stronger position relative to competitors who have more import-dependent and complex supply chains.” Schoeb framed digital strategy around adoption over near-term monetization: “Our priority is building an extensive connected installed base,” with the connected base at “more than 250,000 connected machines.” He said Scan/Pay/Wash “processed over 100,000 transactions in the month of March alone,” and “total transactions in Q1 doubled the entirety of Q4 2025.” CFO Dean Nolden said “first quarter net revenue grew 10% to $427 million,” with “real unit volume increases, contributing roughly 3%,” plus pricing and “roughly 1% benefit from foreign currency.” He reported adjusted EBITDA of “$109 million” and an “adjusted EBITDA margin of 25.5%,” and said operating cash flow was “$80 million.” Schoeb cited balance sheet progress, saying Alliance made “debt payments of $65 million in the quarter” and “reduced net leverage 0.2x to 2.6x adjusted EBITDA.” Outlook Management raised full-year guidance, with Schoeb stating Alliance is “confidence to raise the low end of our full year revenue and adjusted EBITDA guidance today to 6% to 7% revenue growth and 7% to 8% adjusted EBITDA growth.” Nolden said the updated revenue outlook implies “equal contribution expected from volume and price,” and the company expects to realize “price and volume increases and the benefit of continued cost d...
Earnings Call Insights: Ovintiv (OVV) Q1 2026 Management View "We've had a productive start to the year with the successful integration of the recently acquired NuVista assets, the sale of our Anadarko assets and the significant deleveraging of our balance sheet." (President, CEO & Director Brendan McCracken) "In early March, we introduced the next logical progression of our framework... We commit...
Earnings Call Insights: Ovintiv (OVV) Q1 2026 Management View "We've had a productive start to the year with the successful integration of the recently acquired NuVista assets, the sale of our Anadarko assets and the significant deleveraging of our balance sheet." (President, CEO & Director Brendan McCracken) "In early March, we introduced the next logical progression of our framework... We committed to returning 50% to 100% of our free cash flow via dividends and share buybacks." (President, CEO & Director McCracken) "The market has shifted dramatically since then with substantially higher oil prices than we expected... with the higher prices and higher free cash flow, we believe it makes sense to avoid over-indexing on procyclical buybacks... [and] further accelerate net debt reduction." (President, CEO & Director McCracken) "As of April 30, our net debt was less than $3.3 billion or less than 0.8x leverage... We expect to realize over $80 million of annualized interest savings from the debt we've repaid since the start of the year." (Executive VP & CFO Corey Code) "We recorded a $1.2 billion after-tax noncash ceiling test impairment that resulted in a loss in the quarter... At current strip pricing, we do not expect to incur further impairments." (Executive VP & CFO Code) "We hit our 85,000 barrels per day target in the first month after closing the acquisition" and "are already achieving our cost target of $1 million in per well savings... [to] achieve the $100 million in annualized cost synergies that we promised." (Executive VP & COO Gregory Givens) Outlook "Our capital guidance remains unchanged" and "we are maintaining our full year production guidance, including 205,000 to 212,000 barrels per day of oil and condensate." (Executive VP & CFO Code) "In the second quarter, we expect production to average approximately 623,000 BOEs per day, including about 203,000 barrels per day of oil and condensate, and our capital spend is expected to come in at around $575 ...
President Donald Trump says inflation in the US is only "short term." He spoke before leaving for Beijing on Tuesday. US inflation accelerated in April due to rising gasoline and grocery costs, exceeding wage growth. (Source: Bloomberg)
President Donald Trump says inflation in the US is only "short term." He spoke before leaving for Beijing on Tuesday. US inflation accelerated in April due to rising gasoline and grocery costs, exceeding wage growth. (Source: Bloomberg)
Revenues: $5.6 million, 21.1% YoY decrease Transaction Volumes down 32% YoY More than 1,000 Fold Bitcoin Credit Cards in Circulation Restructuring fees on Bitcoin Gift Card to Drive Distribution
Revenues: $5.6 million, 21.1% YoY decrease Transaction Volumes down 32% YoY More than 1,000 Fold Bitcoin Credit Cards in Circulation Restructuring fees on Bitcoin Gift Card to Drive Distribution
Micron (NASDAQ: MU) is becoming a critical player in the AI memory shortage, and its connection to n ext-generation AI platforms could reshape the stock's growth story. With supply sold out, margins surging, and Wall Street still pricing in cyclical risk, the setup creates a powerful question: Is Micron still undervalued after its massive run? Stock prices used were the market prices of May 4, 202...
Micron (NASDAQ: MU) is becoming a critical player in the AI memory shortage, and its connection to n ext-generation AI platforms could reshape the stock's growth story. With supply sold out, margins surging, and Wall Street still pricing in cyclical risk, the setup creates a powerful question: Is Micron still undervalued after its massive run? Stock prices used were the market prices of May 4, 2026. The video was published on May 11, 2026. Continue reading
NeuroPace press release ( NPCE ): Q1 Revenue of $22.1M (-1.8% Y/Y) beats by $0.45M . Cash provided by operations was $8.6 million during Q1 2026, as compared to $7.5 million during Q1 2025. The increase was primarily attributable to an improvement in our operating results, partially offset by lower cash flows provided by working capital changes. As of May 5, 2026, the Company’s issued and outstand...
NeuroPace press release ( NPCE ): Q1 Revenue of $22.1M (-1.8% Y/Y) beats by $0.45M . Cash provided by operations was $8.6 million during Q1 2026, as compared to $7.5 million during Q1 2025. The increase was primarily attributable to an improvement in our operating results, partially offset by lower cash flows provided by working capital changes. As of May 5, 2026, the Company’s issued and outstanding shares were 199,696,597 and its fully diluted shares outstanding were 305,626,935. More on NeuroPace NeuroPace, Inc. (NPCE) Q4 2025 Earnings Call Transcript NeuroPace reiterates $98M–$100M 2026 revenue target while advancing AI and IGE pipeline NeuroPace GAAP EPS of -$0.08 beats by $0.08, revenue of $26.6M beats by $1.81M Seeking Alpha’s Quant Rating on NeuroPace Historical earnings data for NeuroPace
The Southern Poverty Law Center is facing a serious threat from the Justice Department — and comes at a time when several former and current SPLC employees say the group is already deeply vulnerable. (Image credit: Anna Moneymaker)
The Southern Poverty Law Center is facing a serious threat from the Justice Department — and comes at a time when several former and current SPLC employees say the group is already deeply vulnerable. (Image credit: Anna Moneymaker)
Solid Biosciences press release ( SLDB ): Q1 GAAP EPS of -$0.52 misses by $0.08 . Cash Position: Solid had $380.7 million in cash, cash equivalents, and available-for-sale securities as of March 31, 2026, compared to $187.9 million as of December 31, 2025. The Company expects that its existing cash, cash equivalents, and available-for-sale securities will be sufficient to fund its operational runw...
Solid Biosciences press release ( SLDB ): Q1 GAAP EPS of -$0.52 misses by $0.08 . Cash Position: Solid had $380.7 million in cash, cash equivalents, and available-for-sale securities as of March 31, 2026, compared to $187.9 million as of December 31, 2025. The Company expects that its existing cash, cash equivalents, and available-for-sale securities will be sufficient to fund its operational runway into the first half of 2028. More on Solid Biosciences Solid Biosciences Inc. (SLDB) Presents at Barclays 28th Annual Global Healthcare Conference Transcript Solid Biosciences: Interim Data Lends Credibility For Q1 2026 Trial Start Solid Biosciences Inc. (SLDB) Presents at Guggenheim Securities Emerging Outlook: Biotech Summit 2026 Transcript Solid Bio wins new Buy at Guggenheim on lead asset Solid Bio falls amid new trial data for Duchenne drug
For much of 2026, the chip trade has been the only show on Wall Street. The iShares Semiconductor ETF (SOXX) is still up 77% year to date through May 11, Advanced Micro Devices (NASDAQ:AMD) has more than doubled, and Intel (NASDAQ:INTC) has been the comeback story of the cycle. But today, the bid disappeared. SOXX ... Chip Stocks Are Bleeding Today. The 2018 and 2022 Selloffs Tell You Exactly What...
For much of 2026, the chip trade has been the only show on Wall Street. The iShares Semiconductor ETF (SOXX) is still up 77% year to date through May 11, Advanced Micro Devices (NASDAQ:AMD) has more than doubled, and Intel (NASDAQ:INTC) has been the comeback story of the cycle. But today, the bid disappeared. SOXX ... Chip Stocks Are Bleeding Today. The 2018 and 2022 Selloffs Tell You Exactly What Comes Next
(RTTNews) - Canadian stocks edged higher on Tuesday as traders watched the developments in the U.S.-Iran standoff after reports indicated that the U.S. could restart combat operations while refraining from big moves. Gains in the oil-linked energy sector lifted the index against
(RTTNews) - Canadian stocks edged higher on Tuesday as traders watched the developments in the U.S.-Iran standoff after reports indicated that the U.S. could restart combat operations while refraining from big moves. Gains in the oil-linked energy sector lifted the index against
Savara press release ( SVRA ): Q1 GAAP EPS of -$0.15 misses by $0.01 . As of March 31, 2026, the Company had cash, cash equivalents and short-term investments of ~$202.8 million and debt of ~$30.1 million. More on Savara Savara gets FDA review extension for lead asset Savara GAAP EPS of -$0.13 Seeking Alpha’s Quant Rating on Savara Historical earnings data for Savara Financial information for Sava...
Savara press release ( SVRA ): Q1 GAAP EPS of -$0.15 misses by $0.01 . As of March 31, 2026, the Company had cash, cash equivalents and short-term investments of ~$202.8 million and debt of ~$30.1 million. More on Savara Savara gets FDA review extension for lead asset Savara GAAP EPS of -$0.13 Seeking Alpha’s Quant Rating on Savara Historical earnings data for Savara Financial information for Savara
FEATURE Amazon com was disrupting things again on Tuesday. The online retail giant announced 30-minute rapid deliveries on “thousands of groceries and essentials.” The service is now in Atlanta, Dallas–Fort Worth, Philadelphia, and Seattle, “with rapid expansion underway in dozens more U.
FEATURE Amazon com was disrupting things again on Tuesday. The online retail giant announced 30-minute rapid deliveries on “thousands of groceries and essentials.” The service is now in Atlanta, Dallas–Fort Worth, Philadelphia, and Seattle, “with rapid expansion underway in dozens more U.
zhengzaishuru/iStock via Getty Images Ring Energy ( REI ) down 17.4% post-market Tuesday after launching a public offering of $60M of common shares, with an underwriters option to purchase up to an additional $9M shares. Ring Energy ( REI ) said plans to use the proceeds from the offering for the repayment of outstanding borrowings under its senior secured revolving credit facility, while using an...
zhengzaishuru/iStock via Getty Images Ring Energy ( REI ) down 17.4% post-market Tuesday after launching a public offering of $60M of common shares, with an underwriters option to purchase up to an additional $9M shares. Ring Energy ( REI ) said plans to use the proceeds from the offering for the repayment of outstanding borrowings under its senior secured revolving credit facility, while using any remaining proceeds for general corporate purposes. Mizuho, BofA Securities, and Raymond James are acting as joint book-running managers for the offering. More on Ring Energy Ring Energy: Strategy Change Ring Energy: Evidence Piles Up That The Acquisition Strategy Works Ring Energy Q1 2026 Earnings Call Presentation
Palisade Bio press release ( PALI ): Q1 GAAP EPS of -$0.05 misses by $0.01 . As of March 31, 2026, the Company had cash and cash equivalents of $132.6 million and believes that its cash on hand is sufficient to fund its operations through major clinical development milestones, including a Phase 2 primary efficacy readout of PALI-2108 for UC that is expected in the second half of 2027 and a Phase 2...
Palisade Bio press release ( PALI ): Q1 GAAP EPS of -$0.05 misses by $0.01 . As of March 31, 2026, the Company had cash and cash equivalents of $132.6 million and believes that its cash on hand is sufficient to fund its operations through major clinical development milestones, including a Phase 2 primary efficacy readout of PALI-2108 for UC that is expected in the second half of 2027 and a Phase 2 primary efficacy readout of PALI-2108 CD that is expected in early 2028. More on Palisade Bio Palisade Bio: Undervalued Biotech With Blockbuster Potential, Initiating With A Speculative Buy Rating Palisade Bio drops after early-stage trial data for lead asset Seeking Alpha’s Quant Rating on Palisade Bio Historical earnings data for Palisade Bio Financial information for Palisade Bio
DoubleDown Interactive press release ( DDI ): Q1 GAAP EPADS of $0.71 beats by $0.13 . Revenue of $94.1M (+12.7% Y/Y) misses by $0.53M . More on DoubleDown Interactive DoubleDown Interactive: May Look Cheap On Paper, But It Could Be A Trap DoubleDown Interactive Co., Ltd. (DDI) Q4 2025 Earnings Call Transcript DoubleU offers $184M to acquire remaining DoubleDown Interactive stake Seeking Alpha’s Qu...
DoubleDown Interactive press release ( DDI ): Q1 GAAP EPADS of $0.71 beats by $0.13 . Revenue of $94.1M (+12.7% Y/Y) misses by $0.53M . More on DoubleDown Interactive DoubleDown Interactive: May Look Cheap On Paper, But It Could Be A Trap DoubleDown Interactive Co., Ltd. (DDI) Q4 2025 Earnings Call Transcript DoubleU offers $184M to acquire remaining DoubleDown Interactive stake Seeking Alpha’s Quant Rating on DoubleDown Interactive Historical earnings data for DoubleDown Interactive